Brain, behavior, and immunity
Cure8 research brief
Why This Matters
The study suggests a noninvasive spleen-targeted ultrasound approach can reduce gut and brain inflammation and improve behavior in a mouse colitis model, mediated by vagal signaling—pointing to a possible new avenue for modulating gut-brain interactions in IBD.
Who Should Pay Attention
Researchers in neuroimmunology and gut-brain axis, clinicians interested in neuromodulation, and patients curious about future non-drug therapies for IBD-related anxiety or cognitive issues.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a preclinical (mouse) experiment testing a non-invasive neuromodulation method (focused ultrasound on the spleen). The findings are mechanistic and exploratory: they show changes in inflammatory gene expression, tight-junction protein markers, microbiome composition, and behavior in a chemical colitis model, and dependence on vagal signaling.
The study does not report human data or clinical outcomes in people with IBD, so it does not imply that the technique is safe, effective, or available for patients now. Translation from rodent DSS models to human Crohn's disease or ulcerative colitis is uncertain.
Keep In Mind
This is an animal (mouse) study reported at the abstract level; results do not equate to evidence of safety or benefit in humans. Translation from DSS colitis models to human IBD is limited.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationBrain, behavior, and immunity
AuthorsZih-Yun Pan, Meng-Ting Wu, Chi-Ieong Lau +1 more
InstitutionDepartment of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 6, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Prunella vulgaris Polysaccharide Ameliorates DSS-Induced Ulcerative Colitis by Increasing the Abundance of Ligilactobacillus agilis to Inhibit Inflammation and Preserve Intestinal Barrier Integrity
A plant polysaccharide (PVP) reduced inflammation and preserved intestinal barrier proteins in a mouse model of ulcerative colitis, apparently by increasing a specific gut bacterium. This points to a microbiome-related...
The acid polysaccharides extracted from Moringa leaf improve DSS-induced ulcerative colitis by targeting intestinal microbiota metabolism.
The study suggests a Moringa-derived polysaccharide may reduce inflammation in a mouse model of ulcerative colitis by altering gut microbiota, metabolites, and inflammatory/antioxidant signaling — a potential preclinical...
Extracellular vesicles from pasteurized Akkermansia muciniphila ameliorate inflammatory bowel disease through suppression of STING-driven inflammatory signaling.
This study suggests a new, non‑live (“postbiotic”) approach—extracellular vesicles from pasteurized Akkermansia muciniphila—may reduce inflammation and improve barrier function in an experimental colitis model, which...